First Results from the ADRRAD Trial – Combination Androgen Deprivation Therapy (ADT), Whole Pelvis Radiotherapy (WPRT) and Radium 223 in Recently Diagnosed Metastatic Hormone Sensitive Prostate Cancer (MHSPCa). Issue 3 (March 2018)